ResMed: A Mixed Bag for Investors Amid Rising Competition

Group 1 - The article mentions that Anand Chokkavelu, Emily Flippen, and Jason Moser have no positions in any of the stocks mentioned [1] - The Motley Fool has positions in and recommends ResMed, indicating a positive outlook on the company [1]